BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22665526)

  • 1. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.
    De Keersmaecker K
    Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526
    [No Abstract]   [Full Text] [Related]  

  • 2. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-ALL paradox in cancer.
    Hoang T; Hoang T
    Nat Med; 2010 Nov; 16(11):1185-6. PubMed ID: 21052064
    [No Abstract]   [Full Text] [Related]  

  • 6. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
    Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
    Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
    Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K
    Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
    Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
    Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
    Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
    Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
    Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
    Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
    Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
    Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
    Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
    Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
    Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
    Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
    Riz I; Hawley TS; Johnston H; Hawley RG
    Br J Haematol; 2009 Apr; 145(1):140-3. PubMed ID: 19133982
    [No Abstract]   [Full Text] [Related]  

  • 17. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
    Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
    Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
    Rakowski LA; Lehotzky EA; Chiang MY
    PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of leukemia development caused by PTEN loss.
    Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1409-14. PubMed ID: 21212363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.